Within our study design, supplemented PDMP mainly affected circulating platelets by inducing their activation, which was measured by enhanced P-selectin expression on platelet membranes (CD42b+/CD62p+), particularly, but not exclusively, in HD conditions. This evidence concerns the gene GP1BA and Huntington disease.